Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Relievant Medsystems Stock

Q: Can you buy Relievant Medsystems stock?

You can no longer buy Relievant Medsystemsstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

www.relievant.comHealthcare / Medical DevicesFounded: 2006Funding to Date: $247.66MM

Relievant Medsystems developed a minimally-invasive outpatient procedure aimed at relieving chronic lower back pain. Their procedure, Intracept, focuses on vertebrogenic pain. Relievant Medsystems was founded in 2006 by Rex Peters, Samit Patel, and James Peacock and is headquartered in Minneapolis, MN.

Learn more about Relievant Medsystems IPO

Enterprise Value

Access valuation and stock price for companies like Relievant Medsystems before its M&A.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Relievant Medsystems stock FAQs

Can you buy Relievant Medsystems stock?

You can no longer buy Relievant Medsystems stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Relievant Medsystems stock?

To invest in a private company like Relievant Medsystems through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Relievant Medsystems stock?

You can no longer sell stock of Relievant Medsystems on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Relievant Medsystems stock?

If you hold private company shares of Relievant Medsystems - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Relievant Medsystems stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Relievant Medsystems a public company?

No, Relievant Medsystems is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Featured

Startup News: Acquired companies, a look back for 2023

Learn More

Relievant Medsystems investors also invested in these private companies

New Enterprise Associates

Perplexity, Databricks, TAE Technologies, Tempus, Plaid, Fizz, Cohere Technologies, Automation Anywhere, Fluid Truck, Aquabyte

ONSET Ventures

Relievant Medsystems

Morgenthaler Ventures

Transfix, Evernote, Relievant Medsystems, Big Switch Networks

Canaan Partners

Hermeus, Taptap Send, Turo, Mindtickle, Dragos, Ladder Financial, Papa, ContentSquare, Celestial AI, Paxos

Endeavor Vision

HealthJoy, Nalu, Relievant Medsystems

Lightstone Ventures

Shoulder Innovations, Relievant Medsystems

Team

Management Team

Tyler Binney

Chief Executive Officer, President & Board Member

Christopher Geyen

Chief Financial Officer

Rex Peters

Co-Founder & Chief Operating Officer

Ray Baker MD

Chief Medical Officer

Board Members

Alexander Schmitz

Endeavour Vision

Arthur Taylor

Vensana Capital

Brenton Ahrens

Canaan Partners

Ross Jaffe MD

New Enterprise Associates

Jason Lettmann

Morgenthaler Ventures

Reuters 09/19/2023

Boston Scientific to buy chronic back pain therapy maker Relievant

Medical devices maker Boston Scientific (BSX.N) said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million, gaining access to an FDA-cleared therapy for chronic pain. The Massachusetts-based company is also obliged to pay Relievant additional undisclosed payments based on sales performance over the next three years.

Globe Newswire 02/22/2023

Relievant Medsystems Announces Formal Coverage Recommendation from NASS for Basivertebral Nerve Ablation as a Treatment for Chronic Vertebrogenic Low Back Pain

Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the North American Spine Society (NASS) issued a formal coverage recommendation supportive of basivertebral nerve (BVN) ablation for the treatment of chronic vertebrogenic low back pain.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.